for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Sanofi buys haemophilia specialist for $11.6 bn

Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion. As Silvia Antonioli reports, the French healthcare group says the deal will boost earnings and strengthen its presence in treatments for rare diseases.

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up